Large-scale testing (Phase 3)Study completedNCT00185276
What this trial is testing
Magnevist® Injection Enhanced MRA at Two Dose Levels Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Infrarenal Aorta and Peripheral Arteries
Who this might be right for
Peripheral Vascular Disease
Bayer 365